Antitumor effect of the AP5Z1 small-molecule inhibitor PGG in hepatocellular carcinoma
{{output}}
In this study, small-molecule inhibitors targeting AP5Z1 were developed, and their antitumor activity against hepatocellular carcinoma (HCC) and related mechanisms were evaluated. Candidate molecules were initially screened via computer-aided virtual screening... ...